Evaluation of hemodynamic effects of xenon in dogs undergoing hemorrhagic shock
Carregando...
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.68, n.2, p.231-237, 2013
Resumo
OBJECTIVES: The anesthetic gas xenon is reported to preserve hemodynamic stability during general anesthesia. However, the effects of the gas during shock are unclear. The objective of this study was to evaluate the effect of Xe on hemodynamic stability and tissue perfusion in a canine model of hemorrhagic shock. METHOD: Twenty-six dogs, mechanically ventilated with a fraction of inspired oxygen of 21% and anesthetized with etomidate and vecuronium, were randomized into Xenon (Xe; n = 13) or Control (C; n = 13) groups. Following hemodynamic monitoring, a pressure-driven shock was induced to reach an arterial pressure of 40 mmHg. Hemodynamic data and blood samples were collected prior to bleeding, immediately after bleeding and 5, 20 and 40 minutes following shock. The Xe group was treated with 79% Xe diluted in ambient air, inhaled for 20 minutes after shock. RESULT: The mean bleeding volume was 44 mL.kg(-1) in the C group and 40 mL.kg(-1) in the Xe group. Hemorrhage promoted a decrease in both the cardiac index (p<0.001) and mean arterial pressure (p<0.001). These changes were associated with an increase in lactate levels and worsening of oxygen transport variables in both groups (p<0.05). Inhalation of xenon did not cause further worsening of hemodynamics or tissue perfusion markers. CONCLUSIONS: Xenon did not alter hemodynamic stability or tissue perfusion in an experimentally controlled hemorrhagic shock model. However, further studies are necessary to validate this drug in other contexts.
Palavras-chave
Xenon, Hemorrhagic Shock, General Anesthesia
Referências
- Baumert JH, 2008, BRIT J ANAESTH, V100, P605, DOI 10.1093/bja/aen050
- Baumert JH, 2007, BRIT J ANAESTH, V98, P722, DOI 10.1093/bja/aem083
- Baumert JH, 2005, BRIT J ANAESTH, V94, P727, DOI 10.1093/bja/aei127
- Baumert JH, 2009, J CARDIOTHOR VASC AN, V23, P614, DOI 10.1053/j.jvca.2009.01.028
- Baumert JH, 2005, ACTA ANAESTH SCAND, V49, P743, DOI 10.1111/j.1399-6576.2004.00662.x
- Braz JRC, 2005, ANESTH ANALG, V100, P1867
- Coburn M, 2005, BRIT J ANAESTH, V94, P198, DOI 10.1093/bja/aei023
- CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580
- Francis RCE, 2010, SHOCK, V34, P628, DOI 10.1097/SHK.0b013e3181e682f9
- Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525
- Hanss R, 2006, BRIT J ANAESTH, V96, P427, DOI 10.1093/bja/ael028
- Hartlage MAG, 2004, ANESTH ANALG, V99, P655, DOI 10.1213/01.ANE.0000129999.74324.4E
- Hein M, 2010, ACTA ANAESTH SCAND, V54, P470, DOI 10.1111/j.1399-6576.2009.02116.x
- Hopper J, 1944, J CLIN INVEST, V23, P628, DOI 10.1172/JCI101533
- LACHMANN B, 1990, LANCET, V335, P1413
- LANE GA, 1980, SCIENCE, V210, P899, DOI 10.1126/science.7434002
- LUTTROPP HH, 1993, ANAESTHESIA, V48, P1045
- Marx T, 1997, BRIT J ANAESTH, V78, P326
- Mio Y, 2009, ANESTH ANALG, V108, P858, DOI 10.1213/ane.0b013e318192a520
- Nalos M, 2001, BRIT J ANAESTH, V87, P497, DOI 10.1093/bja/87.3.497
- PITTINGER CB, 1953, ANESTHESIOLOGY, V14, P10, DOI 10.1097/00000542-195301000-00002
- PRIST R, 1992, CIRC SHOCK, V36, P13
- Schroth SC, 2002, ANESTHESIOLOGY, V96, P422, DOI 10.1097/00000542-200202000-00030
- Schwiebert C, 2010, EUR J ANAESTH, V27, P734, DOI 10.1097/EJA.0b013e328335fc4c
- Stowe DF, 2000, ANESTHESIOLOGY, V92, P516, DOI 10.1097/00000542-200002000-00035
- Wappler F, 2007, ANESTHESIOLOGY, V106, P463, DOI 10.1097/00000542-200703000-00010
- Weber NC, 2008, ANESTH ANALG, V107, P1807, DOI [10.1213/ane.Ob013e31818874bf, 10.1213/ane.0b013e31818874bf]